Insights on Clinical Trials
-
Nanoscope Therapeutics Tackling Vision Loss With Ocular Gene Therapy
3/27/2024
Leaders from Nanoscope Therapeutics explain the safety and efficacy data from as well as next steps for the company's RESTORE trial.
-
Inside Tenaya Therapeutics’ AAV9-Based Gene Therapy
3/27/2024
Tenaya Therapeutics' CSO explains how the company's gene therapy, TN-401, may treat heart disease.
-
Reducing The Number Of Clinical Holds On Cell And Gene Therapies: Approaches For Sponsors And The FDA
3/25/2024
There is a large proportion of clinical trials for cell and gene therapies that the FDA places on clinical hold. Why is this, and what can sponsor companies and the FDA do differently?
-
How To Realize The Value Of Patient-Centric Solutions
3/21/2024
Unlock the potential of patient-centric solutions by striking the right balance between innovation and practicality in trial design. Discover how to optimize recruitment, retention, and outcomes.
-
How Different Are Oncology Clinical Trials?
3/19/2024
Oncology clinical trials pose unique challenges. Dive into five key reasons behind the intricacies of oncology trials, from recruitment hurdles to data volume and efficacy endpoints.
-
The Workhorse Of Today’s Clinical Trials
3/19/2024
Unlock the power of decentralized clinical trials with an electronic data capture platform (EDC). Discover how stakeholders benefit and what to consider when choosing the right EDC system.
-
Quality Versus Quantity In T-Cell Production
3/15/2024
Technological advances have made it possible to produce high-quality T cells at scale, providing a boon for T-cell manufacturing.
-
CRISPR Clinical Trials To Follow In 2024 And Beyond
3/13/2024
CRISPR therapies are being developed for genetic disorders, cancer, and infectious diseases. Explore which CRISPR clinical trials are worth keeping an eye on this year.
-
Precision Oncology Clinical Trials And Statistics 2024
3/12/2024
Delve into the latest advancements in clinical trials, targeted therapies, and the promising horizon of cancer care.
-
Duchenne Muscular Dystrophy - Global Clinical Trial Landscape (2024)
3/11/2024
Explore how this comprehensive approach can offer hope for improved outcomes and quality of life for DMD patients, highlighting global commitment to tackling this complex disorder.